When Do You Feel the Effects of Wegovy — and What Should You Expect?

Appetite change often comes first: reduced hunger and earlier fullness are usually the earliest signs that semaglutide is working, often in the first week or two.
Weight loss follows gradually: most people see measurable changes on the scales from weeks four to eight, with the most significant losses accumulating over months, not days.
Each dose increase resets the curve: when your prescriber moves you to a higher dose, the same adjustment period restarts, effects deepen, and so can temporary side effects.
The full picture takes time: the STEP 1 trial ran for 68 weeks; the largest average losses appeared at 12 months and beyond, not in the early weeks.

Most people begin to feel the effects of Wegovy within the first one to two weeks of starting treatment, though meaningful weight loss typically becomes visible after four to eight weeks. The appetite-suppressing effects of semaglutide often arrive before the scales move — a quieter internal signal that many patients describe as simply feeling full sooner. Wegovy is a prescription-only medicine, so a clinician assesses your suitability before treatment begins; what you experience and when will depend on your dose, your body, and how your treatment is titrated by your prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How Wegovy's effects unfold over weeks and months, a realistic timeline

The first injection: what's actually happening inside you

You've done the first injection, and now you're waiting. That feeling (part hope, part impatience) is completely understandable, and almost everyone starting Wegovy goes through it.

Semaglutide works by activating GLP-1 receptors in the brain and gut. It slows the rate at which food leaves your stomach, raises signals of fullness, and damps down the appetite circuits that, for many people, have been working against them for years. These mechanisms don't switch on overnight, but they do begin immediately after your first dose.

Within a day or two, semaglutide reaches measurable levels in your blood. By the end of the first week, many people notice that meals feel satisfying sooner than usual, or that the pull towards snacking between meals is quieter than normal. The semaglutide injection starts at a low 0.25mg dose precisely to let your system adjust before the therapeutic work begins in earnest, so the appetite effects at this stage are gentle, not dramatic. Some people feel nothing obvious at all for the first fortnight, and that's within normal range.

The NHS's patient information for semaglutide explains the mechanism and early-stage experience clearly if you want to read further alongside your Patient Information Leaflet.

Weeks four to twelve: when the scales begin to shift

This is typically when patients report their first clear weight changes. By week four you will have completed your starter month and, if your prescriber agrees, moved to the next dose level. That transition matters: higher doses produce stronger appetite suppression and faster gastric slowing, which is why the titration schedule exists.

A realistic expectation for this window is a few pounds to several kilograms, depending on how closely a reduced-calorie diet and activity are maintained alongside treatment. Weight loss is rarely linear, there are weeks where nothing moves, followed by weeks where it does. That's normal physiology, not a sign the medicine has stopped working.

Gastrointestinal side effects (nausea, loose stools, indigestion) are most common in this window too, particularly in the days after a dose increase. They tend to ease as your body adjusts, usually within a couple of weeks of each new dose. You can read a fuller account of what effects to expect from Wegovy and how to manage them.

If you're weighing up the cost of continuing treatment at this stage, a clear breakdown of what Wegovy costs through different UK providers may be useful context before your next prescription review.

Three months to one year: where the real results accumulate

The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults on 2.4mg semaglutide for 68 weeks. Average weight reduction was around 15% of body weight, but that number was built over more than a year, not a sprint. The sharpest losses tended to occur between months three and nine, with results plateauing as patients approached their maintenance dose and body weight found a new set point.

This matters for expectations. Asking when you'll feel the effects of Wegovy is really two questions: when appetite changes (early, often within a fortnight) and when weight loss becomes meaningful (months, not weeks). Both are genuine effects; they just run on different clocks.

By the time most patients reach 2.4mg, which can take around five months of titration, the appetite effects are considerably stronger than at 0.25mg. Cravings are often described as having less hold. Portion sizes that would once have felt unsatisfying may now feel like enough. That shift (quiet, cumulative) is what drives the trial outcomes.

For a closer look at the broader timeline and what factors influence it, when the effects of Wegovy start covers the detail from a slightly different angle.

What slows the effects down, and what that means for your treatment

Several things can delay or soften the effects. Missing doses disrupts the steady-state concentration that semaglutide needs to work well; consistency matters more than most patients realise early on. Dietary habits alongside treatment also play a significant role, semaglutide reduces appetite but doesn't override calorie intake entirely, and alcohol in particular can stall progress.

Biological factors also vary between individuals: gut motility, existing metabolic conditions, other medicines, and starting weight all influence the timeline. This is why how quickly semaglutide takes effect differs from one person to the next, even on identical doses.

If you've been on Wegovy for six months at the highest tolerated dose and haven't lost at least 5% of your starting weight, NICE guidance suggests reviewing whether to continue, that's a conversation to have with your prescriber, not a reason to stop without discussion. Our frequently asked questions cover what to do if results feel slower than expected.

Questions about your individual response, whether to continue, or how your dose should progress belong with a clinician. A prescriber who knows your history gives far better guidance than a general timeline. If you'd like that clinical conversation, check your eligibility with our prescribers.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions